Secondary bacterial infection in COVID-19 patients is associated with increased mortality
and disproportionately affects critically ill patients. This single-centre retrospective …

Antimicrobial resistance (AMR) is a well-known global threat due to the subsequent increase
in antimicrobial usage. Several antimicrobial stewardship (AMS) strategies have been …

Antibacterial prescribing in patients presenting with COVID-19 remains discordant to rates of
bacterial co-infection. Implementing diagnostic tests to exclude bacterial infection may aid …

Background Blood biomarkers have the potential to help identify COVID-19 patients with
bacterial coinfection in whom antibiotics are indicated. During the COVID-19 pandemic …

The development of secondary bacterial infections in COVID-19 patients has been
associated with increased mortality and worse clinical outcomes. Consequently, many …

Admission procalcitonin measurements and microbiology results were available for 1040
hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International …

Background and Objectives: An elevated procalcitonin level has classically been linked to
bacterial infections. Data on the association between elevated procalcitonin and the …

Background: We sought to determine if there was a difference in the longitudinal
inflammatory response measured by white blood cell count (WBC), C-reactive protein …

Background A low procalcitonin (PCT) concentration facilitates exclusion of bacterial co-
infections in COVID-19, but high costs associated with PCT measurements preclude …

Bacterial and viral sepsis induce alterations of all hematological parameters and
procalcitonin is used as a biomarker of infection and disease severity. Our aim was to study …